Delivery Order SPE2DB20D3101-SPE2DB24FRFS4

Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.34 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a period of performance through November 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The $3,206.04 firm fixed-price delivery order is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that runs through November 2026. This IDC enables efficient government procurement of essential pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 firm-fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML syringes, a specialty medication. The contract has a period of performance through November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.36 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a completion date of July 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,507.19 contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a specialty medication, with a completion date of May 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $1,055.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with an ultimate completion date of November 15, 2024. The contract utilizes a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is a delivery order (SPE2DB20D2104|SPE2DB24FT85P) worth $1,581.52 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a specialty medication, with a completion date of April 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB24FU1Q0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,211.46 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a specialty medication. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,883.33 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a prescription medication, with a completion date of September 22, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a ceiling value of $1,844.56 and a completion date of June 5, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRFS4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 delivery order contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a prescription medication.

The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:04 AM